Latest Pharmerica Corp (PMC) Headlines
NYSE stocks posting largest percentage increases
AP - Wed Mar 12, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Upgrade Alert for PharMerica (PMC)
Comtex SmarTrend(R) - Wed Mar 12, 7:07AM CDT
PharMerica (NYSE
MC) was upgraded from Neutral to Outperform at Credit Suisse today. The stock closed yesterday at $24.76 on volume of 180,000 shares, below average daily volume of 299,000. PharMerica Corporation is a pharmaceutical services firm. The Company provides services to patients in hospitals and long term care settings.
PharMerica to Present at the Barclays Global Healthcare Conference
Business Wire - Mon Mar 10, 7:01AM CDT
PharMerica Corporation (NYSEMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the Barclays Global Healthcare Conference in Miami, Florida on Thursday, March 13, 2014, at 8:00 a.m. Eastern Time.
PharMerica Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Fri Feb 28, 7:00AM CST
--Specialty Infusion and Oncology Businesses Expected to Generate Annual Revenues of Approximately $400 Million by 2016
IMBRUVICA(TM) Approved for Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360(R)
Business Wire - Thu Feb 13, 7:30AM CST
Onco360, the nation's fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA(TM) (ibrutinib). IMBRUVICA(TM) is now also indicated for the treatment of patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy. This indication is based on overall response rate. An improvement in survival or disease-related symptoms has not been established.
Can Health Net (HNT) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:30PM CST
Health Net, Inc. is set to report fourth-quarter 2013 results on Feb 11.
Can DaVita HealthCare Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:20PM CST
DaVita HealthCare Partners Inc. is set to report fourth-quarter 2013 results on Feb 11.
Will Humana (HUM) Miss Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 12:30PM CST
Humana Inc. is set to report fourth-quarter 2013 results on Feb 5, 2014
Deloitte Corporate Finance LLC Advises Sina Drug Corporation in its Investment from PharMerica Corporation
PR Newswire - Tue Feb 04, 6:55AM CST
Deloitte Corporate Finance LLC ("DCF") acted as the exclusive financial advisor to Sina Drug Corporation (DBA "Onco360") in its investment from PharMerica Corporation ("PharMerica"). As the largest independent provider of oncology pharmacy services in the United States, Onco360 will serve as a key strategic addition to PharMerica's pharmacy and care management platform.
Shares of PMC Up 67.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 03, 9:09AM CST
SmarTrend identified an Uptrend for PharMerica (NYSEMC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 67.88% as of today's recent price of $24.25.
PharMerica Corporation to Broadcast Fourth Quarter 2013 Results Conference Call Live on the Internet
Business Wire - Fri Jan 31, 8:00AM CST
PharMerica Corporation (NYSEMC) announced today that it will provide an online simulcast of its fourth quarter 2013 earnings conference call on Friday, February 28, 2014. The Company's results for the fourth quarter ended December 31, 2013, will be released before the open of the market on Friday, February 28, 2014.
Is WellPoint (WLP) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 28, 10:20AM CST
We expect health benefits company, WellPoint Inc. to beat expectations when it reports fourth-quarter 2013 results on Jan 29, 2014.
76.9% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Fri Jan 24, 4:39PM CST
SmarTrend identified an Uptrend for PharMerica (NYSEMC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 76.95% as of today's recent price of $25.56.
Uptrend Call Working As PharMerica Stock Rises 71.8% (PMC)
Comtex SmarTrend(R) - Fri Jan 17, 11:00AM CST
SmarTrend identified an Uptrend for PharMerica (NYSEMC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 71.82% as of today's recent price of $24.82.
DMO to Raise N270 Billion in First Quarter
by Eromosele Abiodun - All Africa Global Media - Fri Jan 17, 2:09AM CST
The Debt Management Office (DMO) is to raise between N200 billion ($1.26 billion) and N270 billion ($1.70 billion) from the sale of FGN bonds in the first quarter of 2014, according to its provisional calendar.
Stock Price Movements, Completion of Acquisitions, and Clinical Trial Initiations - Research Report on Endocyte, PharMerica, Synta, AtriCure, and Cytokinetics
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Why the Earnings Streak Will Continue for PharMerica (PMC) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 7:33AM CST
Looking for a stock that might be in a good position to beat earnings at its next report? Consider PharMerica Corporation (PMC), a firm in the Pharmacy Services industry, which could be a great candidate for another beat.
PharMerica to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 13, 8:03AM CST
PharMerica Corporation (NYSEMC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 16, 2014, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
NYSE stocks posting largest percentage increases
AP - Wed Mar 12, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Upgrade Alert for PharMerica (PMC)
Comtex SmarTrend(R) - Wed Mar 12, 7:07AM CDT
PharMerica (NYSE
MC) was upgraded from Neutral to Outperform at Credit Suisse today. The stock closed yesterday at $24.76 on volume of 180,000 shares, below average daily volume of 299,000. PharMerica Corporation is a pharmaceutical services firm. The Company provides services to patients in hospitals and long term care settings. PharMerica to Present at the Barclays Global Healthcare Conference
Business Wire - Mon Mar 10, 7:01AM CDT
PharMerica Corporation (NYSE
MC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the Barclays Global Healthcare Conference in Miami, Florida on Thursday, March 13, 2014, at 8:00 a.m. Eastern Time. PharMerica Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Fri Feb 28, 7:00AM CST
--Specialty Infusion and Oncology Businesses Expected to Generate Annual Revenues of Approximately $400 Million by 2016
IMBRUVICA(TM) Approved for Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360(R)
Business Wire - Thu Feb 13, 7:30AM CST
Onco360, the nation's fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA(TM) (ibrutinib). IMBRUVICA(TM) is now also indicated for the treatment of patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy. This indication is based on overall response rate. An improvement in survival or disease-related symptoms has not been established.
Can Health Net (HNT) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:30PM CST
Health Net, Inc. is set to report fourth-quarter 2013 results on Feb 11.
Can DaVita HealthCare Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:20PM CST
DaVita HealthCare Partners Inc. is set to report fourth-quarter 2013 results on Feb 11.
Will Humana (HUM) Miss Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 12:30PM CST
Humana Inc. is set to report fourth-quarter 2013 results on Feb 5, 2014
Deloitte Corporate Finance LLC Advises Sina Drug Corporation in its Investment from PharMerica Corporation
PR Newswire - Tue Feb 04, 6:55AM CST
Deloitte Corporate Finance LLC ("DCF") acted as the exclusive financial advisor to Sina Drug Corporation (DBA "Onco360") in its investment from PharMerica Corporation ("PharMerica"). As the largest independent provider of oncology pharmacy services in the United States, Onco360 will serve as a key strategic addition to PharMerica's pharmacy and care management platform.
Shares of PMC Up 67.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 03, 9:09AM CST
SmarTrend identified an Uptrend for PharMerica (NYSE
MC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 67.88% as of today's recent price of $24.25. PharMerica Corporation to Broadcast Fourth Quarter 2013 Results Conference Call Live on the Internet
Business Wire - Fri Jan 31, 8:00AM CST
PharMerica Corporation (NYSE
MC) announced today that it will provide an online simulcast of its fourth quarter 2013 earnings conference call on Friday, February 28, 2014. The Company's results for the fourth quarter ended December 31, 2013, will be released before the open of the market on Friday, February 28, 2014. Is WellPoint (WLP) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 28, 10:20AM CST
We expect health benefits company, WellPoint Inc. to beat expectations when it reports fourth-quarter 2013 results on Jan 29, 2014.
76.9% Return Seen to Date on SmarTrend PharMerica Call (PMC)
Comtex SmarTrend(R) - Fri Jan 24, 4:39PM CST
SmarTrend identified an Uptrend for PharMerica (NYSE
MC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 76.95% as of today's recent price of $25.56. Uptrend Call Working As PharMerica Stock Rises 71.8% (PMC)
Comtex SmarTrend(R) - Fri Jan 17, 11:00AM CST
SmarTrend identified an Uptrend for PharMerica (NYSE
MC) on October 4th, 2013 at $14.45. In approximately 4 months, PharMerica has returned 71.82% as of today's recent price of $24.82. DMO to Raise N270 Billion in First Quarter
by Eromosele Abiodun - All Africa Global Media - Fri Jan 17, 2:09AM CST
The Debt Management Office (DMO) is to raise between N200 billion ($1.26 billion) and N270 billion ($1.70 billion) from the sale of FGN bonds in the first quarter of 2014, according to its provisional calendar.
Stock Price Movements, Completion of Acquisitions, and Clinical Trial Initiations - Research Report on Endocyte, PharMerica, Synta, AtriCure, and Cytokinetics
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Why the Earnings Streak Will Continue for PharMerica (PMC) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 7:33AM CST
Looking for a stock that might be in a good position to beat earnings at its next report? Consider PharMerica Corporation (PMC), a firm in the Pharmacy Services industry, which could be a great candidate for another beat.
PharMerica to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 13, 8:03AM CST
PharMerica Corporation (NYSE
MC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 16, 2014, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). 
